Outpatient intravenous treatment for infective endocarditis: Safety, effectiveness and one-year outcomes

Sexton, 1998, Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group, Clin Infect Dis, 27, 1470, 10.1086/515038 Francioli, 1995, Treatment of streptococcal endocarditis with a single daily dose of ceftriaxone and netilmicin for 14 days: a prospective multicenter study, Clin Infect Dis, 21, 1406, 10.1093/clinids/21.6.1406 Stamboulian, 1991, Antimicrobial management of outpatients with endocarditis due to penicillin-susceptible streptococci, Rev Infect Dis, 13, S160, 10.1093/clinids/13.Supplement_2.S160 Tice, 2004, Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines, Clin Infect Dis, 38, 1651, 10.1086/420939 Andrews, 2001, Patient selection criteria and management guidelines for outpatient parenteral antimicrobial therapy for native valve infective endocarditis, Clin Infect Dis, 33, 203, 10.1086/321814 Monteiro, 2001, Outpatient Management of Infective Endocarditis, Curr Infect Dis Rep, 3, 319, 10.1007/s11908-001-0068-6 McMahon, 2008, Victorian HITH Outcomes Study Group, Lindsay GM. Is hospital-in-the-home (HITH) treatment of bacterial endocarditis safe and effective?, Scand J Infect Dis, 40, 40, 10.1080/00365540701522942 Lopardo, 2001, Management of endocarditis: outpatient parenteral antimicrobial treatment in Argentina, Chemotherapy, 47, 24, 10.1159/000048565 Dimayuga, 1995, Outpatient parenteral antimicrobial therapy for infective endocarditis, Infect Dis Clin Pract, 4, 468, 10.1097/00019048-199511000-00031 Huminer, 1999, Home intravenous antimicrobial therapy for patients with infective endocarditis, Eur J Clin Microbiol Infect Dis, 18, 330, 10.1007/PL00015014 Hughes, 2009, Continuous versus intermittent infusion of oxacillin for treatment of infective endocarditis caused by methicillin-susceptible Staphylococcus aureus, Antimicrob Agents Chemother, 53, 2014, 10.1128/AAC.01232-08 Leder, 1999, The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis, J Antimicrob Chemother, 43, 113, 10.1093/jac/43.1.113 Baddour, 2005, Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications, Circulation, 111, e394, 10.1161/CIRCULATIONAHA.105.165564 Li, 2000, Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin Infect Dis, 30, 633, 10.1086/313753 Fowler, 2005, ICE Investigators. Staphylococcus aureus endocarditis: a consequence of medical progress, JAMA, 293, 3012, 10.1001/jama.293.24.3012 Campbell, 2001, A systematic review of discharge coding accuracy, J Public Health Med, 23, 205, 10.1093/pubmed/23.3.205 Murdoch, 2009, Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study, Arch Intern Med, 169, 463, 10.1001/archinternmed.2008.603 Miro, 2005, Staphylococcus aureus native valve infective endocarditis: report of 566 episodes from the International Collaboration on Endocarditis Merged Database, Clin Infect Dis, 41, 507, 10.1086/431979 Cabell, 2002, Changing patient characteristics and the effect on mortality in endocarditis, Arch Intern Med, 162, 90, 10.1001/archinte.162.1.90 Huggan, 2008, Concomitant Staphylococcus aureus bacteriuria is associated with poor clinical outcome in adults with S. aureus bacteraemia, J Hosp Infect, 69, 345, 10.1016/j.jhin.2008.04.027 Hill, 2001, Prospective study of 424 cases of Staphylococcus aureus bacteraemia: determination of factors affecting incidence and mortality, Intern Med J, 31, 97, 10.1111/j.1444-0903.2001.00029.x Dworkin, 1989, Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin, Lancet, 2, 1071, 10.1016/S0140-6736(89)91083-0 Heldman, 1996, Oral antimicrobial treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy, Am J Med, 101, 68, 10.1016/S0002-9343(96)00070-8 Wynn, 2005, Evaluation of the efficacy and safety of outpatient parenteral antimicrobial therapy for infections with methicillin-sensitive Staphylococcus aureus, Southampt Med J, 98, 590, 10.1097/01.SMJ.0000145300.28736.BB Upton, 2004, Outpatient Parenteral Antimicrobial Therapy (OPAT): a review of experience at Auckland Hospital, N Z Med J, 117, U1020 Tornos, 1992, Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study, Ann Intern Med, 117, 567, 10.7326/0003-4819-117-7-567 Turnidge, 1998, The pharmacodynamics of beta-lactams, Clin Infect Dis, 27, 10, 10.1086/514622 Chambers, 2002, Home intravenous antimicrobial service–twelve months experience in Christchurch, N Z Med J, 115, 216 Vella-Brincat, 2007, Protein binding of cefazolin is saturable in vivo both between and within patients, Br J Clin Pharmacol, 63, 753, 10.1111/j.1365-2125.2006.02827.x Nannini, 2003, Relapse of type A beta-lactamase-producing Staphylococcus aureus native valve endocarditis during cefazolin therapy: revisiting the issue, Clin Infect Dis, 37, 1194, 10.1086/379021